LEXX
Lexaria Bioscience Corp
NASDAQ: LEXX · HEALTHCARE · BIOTECHNOLOGY
$0.66
-4.34% today
Updated 2026-04-30
Market cap
$23.56M
P/E ratio
—
P/S ratio
64.01x
EPS (TTM)
$-0.47
Dividend yield
—
52W range
$0 – $2
Volume
0.2M
Lexaria Bioscience Corp (LEXX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-7,260.00%
ROE
-147.10%
ROA
-76.00%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $253147.00 | $-1.06M | -8.27% | -418.06% | -417.10% |
| 2007 | $900789.00 | $-978490.00 | 10.53% | -42.70% | -108.63% |
| 2008 | $421955.00 | $-753573.00 | -30.25% | -115.74% | -178.59% |
| 2009 | $362471.00 | $-552462.00 | 24.23% | -98.85% | -152.42% |
| 2010 | $1.13M | $-538226.00 | 41.06% | -22.89% | -47.47% |
| 2011 | $1.36M | $-251508.00 | 42.31% | -1.02% | -18.52% |
| 2012 | $1.10M | $-343551.00 | 27.54% | -5.18% | -31.30% |
| 2013 | $1.10M | $-343551.00 | 27.54% | -6.94% | -31.30% |
| 2014 | $1.10M | $-1.87M | 27.54% | 26.79% | -170.50% |
| 2015 | $14702.00 | $-1.77M | -103.26% | -13,115.30% | -12,042.58% |
| 2016 | $40718.00 | $-1.21M | -13.55% | -3,093.51% | -2,983.38% |
| 2017 | $63639.00 | $-1.87M | 50.91% | -3,022.44% | -2,937.31% |
| 2018 | $433287.00 | $-6.60M | 93.66% | -1,526.28% | -1,522.97% |
| 2019 | $222610.00 | $-4.10M | -87.16% | -1,860.64% | -1,841.53% |
| 2020 | $314793.00 | $-3.93M | 22.02% | -1,311.63% | -1,249.71% |
| 2021 | $722738.00 | $-4.03M | 75.74% | -763.84% | -557.19% |
| 2022 | $255396.00 | $-7.27M | 18.29% | -2,545.40% | -2,846.30% |
| 2023 | $226208.00 | $-6.66M | 23.86% | -2,888.50% | -2,946.36% |
| 2024 | $464278.00 | $-5.80M | 82.56% | -1,226.70% | -1,248.25% |
| 2025 | $705923.00 | $-11.90M | 83.20% | -1,647.97% | -1,686.00% |